Evidence map›Paper›PMID 26310677›Full record

ArticleClinical orthopaedics and related research2016

Early Lessons From a Worldwide, Multicenter, Followup Study of the Recalled Articular Surface Replacement Hip System.

Rami Madanat, Daniel K Hussey, Gabrielle S Donahue, Hollis G Potter, Robert Wallace, Charles Bragdon, Orhun Muratoglu, Henrik Malchau

Registry-linked trialOpen access · bronzeAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Clinical orthopaedics and related research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01611233 (Clinical Follow-up of ASR Patients Post-Recall), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01611233 unknown statusnot on this map

Clinical Follow-up of ASR Patients Post-Recall

TypeobservationalSponsorMassachusetts General HospitalRan2012 to 2022Enrolled1,950ConditionsOsteoarthritis
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Rami MadanatHarris Orthopaedic Laboratory, Massachusetts General Hospital, 55 Fruit Street, GRJ 1231, Boston, MA, 02114, USA.
Daniel K HusseyHarris Orthopaedic Laboratory, Massachusetts General Hospital, 55 Fruit Street, GRJ 1231, Boston, MA, 02114, USA.
Gabrielle S DonahueHarris Orthopaedic Laboratory, Massachusetts General Hospital, 55 Fruit Street, GRJ 1231, Boston, MA, 02114, USA.
Hollis G PotterDepartment of Radiology and Imaging, Hospital for Special Surgery, New York, NY, USA.
Robert WallaceSportsmed SA, Stepney, Australia.
Charles BragdonHarris Orthopaedic Laboratory, Massachusetts General Hospital, 55 Fruit Street, GRJ 1231, Boston, MA, 02114, USA.
Orhun MuratogluHarris Orthopaedic Laboratory, Massachusetts General Hospital, 55 Fruit Street, GRJ 1231, Boston, MA, 02114, USA.
Henrik MalchauHarris Orthopaedic Laboratory, Massachusetts General Hospital, 55 Fruit Street, GRJ 1231, Boston, MA, 02114, USA. hmalchau@partners.org.
Massachusetts General Hospital · USHospital for Special Surgery · USSports Medicine Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdverse local tissue reactions (ALTRs) around hip arthroplasties are an important reason for failure of metal-on-metal (MoM) hip implants. Little is known about capsular dehiscence patterns as ALTRs decompress from the hip into the surrounding tissue planes; these patterns may also influence the onset and severity of patient symptoms. QUESTIONS/PURPOSES: Through a multicenter study approach, we asked: (1) Is ALTR location related to the surgical approach used for arthroplasty in patients who underwent hip arthroplasty (resurfacing or THA) with a single, recalled hip arthroplasty system? (2) Do ALTR severity and location affect patient-reported outcomes in these patients? (3) Is ALTR severity different between patients who received the resurfacing version of this component (Articular Surface Replacement [ASR]) and those who received the THA implant in this system (ASR XL)?

methodsIn a multicenter prospective study of patients who had undergone surgery with use of the ASR and ASR XL hip system (DePuy Orthopaedics, Warsaw, IN, USA), 288 patients (333 hips) from two centers had a metal artifact reduction sequence MRI of the hip performed at a mean time of 6 years postsurgery. Procedures included 166 hips (50%) with ASR resurfacing and 167 hips (50%) with ASR XL THA performed between 2004 and 2010. One hundred twenty-nine hips (39%) had been operated on using a direct lateral approach and 204 using a posterior approach (61%). The EQ-5D, Harris hip score, UCLA activity score, and visual analog scale pain score were obtained for each patient. ALTRs were classified using the Anderson ALTR grading system, and the location, synovial thickness, and diameter of the ATLRs were assessed. The relationship between ALTR location and surgical approach as well as for ALTR severity and patient-reported outcomes were evaluated, and logistic regression was used to identify predictors for moderate-to-severe ALTRs.

resultsModerate or severe ALTRs were identified in 79 hips (24%); 41 of these hips had been operated on using the direct lateral approach and 38 using the posterior approach. In patients in whom the lateral approach was used, 83% had an anterior ALTR. Similarly, 71% of patients in the posterior approach group had posterior ALTRs. There were no differences in patient-reported outcome measures between patients with moderate-to-severe ALTRs and those with no ALTR findings on MRI (p > 0.09). Use of ASR XL was an independent risk factor for moderate-to-severe ALTRs (odds ratio, 2.8; 95% confidence interval, 1.4-5.5 p = 0.004) and patients with ASR XL also had a thicker synovium (median ASR XL = 3.6 mm [1.2-10.6 mm], median ASR = 2.6 mm [1.2-10.7 mm], p < 0.001) and larger maximal ALTR diameter (median ASR XL = 47.6 mm [14-109.70 mm], median ASR = 38.4 [17.2-118.0 mm], p = 0.02) than patients treated with ASR.

conclusionsThe location of ALTRs can be predicted based on the previous surgical approach to the hip. Patients with ASR XL are more likely to develop moderate-to-severe ALTRs compared with ASR patients. An extensive range of patient-reported outcome measures may not identify all patients with ALTRs further supporting the use of MRI as a screening measure for ALTRs. LEVEL OF EVIDENCE: Level II, therapeutic study.

Indexed as

Medical Device RecallsProsthesis FailureAdultAgedAged, 80 and overArthroplasty, Replacement, HipAustraliaBiomechanical PhenomenaDisability EvaluationEuropeFemaleFollow-Up StudiesForeign-Body ReactionHip JointHip ProsthesisHumans

Identifiers

PMID26310677
PMCPMC4686517
OpenAlexW2097981902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.